Zoledronic acid slows down rat primary chondrosarcoma development, recurrente tumor progression after intralesional curretage and increases overall survival

Zoledronic acid slows down rat primary c

Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival

✍ François Gouin; Benjamin Ory; François Rédini; Dominique Heymann 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 206 KB

## Abstract Chondrosarcoma is a difficult musculoskeletal tumor to treat. Surgical treatment leads to severe disability, with high rates of local recurrence and life threat. No adjuvant therapy is effective in differentiated chondrosarcomas. Bisphosphonates (BPs) are a class of molecules which is e